These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 27774443)
1. The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease. Abej E; El-Matary W; Singh H; Bernstein CN Can J Gastroenterol Hepatol; 2016; 2016():2483261. PubMed ID: 27774443 [No Abstract] [Full Text] [Related]
2. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases. Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study. Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers. Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH; Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483 [TBL] [Abstract][Full Text] [Related]
5. Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease. Inokuchi T; Kato J; Hiraoka S; Takashima S; Nakarai A; Takei D; Sugihara Y; Takahara M; Kawano S; Harada K; Okada H Inflamm Bowel Dis; 2016 May; 22(5):1078-85. PubMed ID: 26891256 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test. Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769 [TBL] [Abstract][Full Text] [Related]
7. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease. E Penna FGC; Rosa RM; da Cunha PFS; de Souza SCS; de Abreu Ferrari ML BMC Gastroenterol; 2020 Feb; 20(1):35. PubMed ID: 32054445 [TBL] [Abstract][Full Text] [Related]
8. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease. Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259 [TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon. Jensen MD; Kjeldsen J; Nathan T Scand J Gastroenterol; 2011 Jun; 46(6):694-700. PubMed ID: 21456899 [TBL] [Abstract][Full Text] [Related]
10. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis. Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625 [TBL] [Abstract][Full Text] [Related]
11. The use of serum calprotectin as a biomarker for inflammatory activity in inflammatory bowel disease. Suárez Ferrer C; Abadía Barno M; Martín Arranz E; Jochems A; García Ramírez L; Poza Cordón J; Jaquotot Herranz M; Cerpa Arencibia A; Martín Arranz MD Rev Esp Enferm Dig; 2019 Oct; 111(10):744-749. PubMed ID: 31476872 [TBL] [Abstract][Full Text] [Related]
12. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease. Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M Dig Dis Sci; 2017 Nov; 62(11):3123-3130. PubMed ID: 28948412 [TBL] [Abstract][Full Text] [Related]